Literature DB >> 7981147

Activation of high endothelial venules in peripheral lymph nodes. The involvement of interferon-gamma.

G Kraal1, K Schornagel, H Savelkoul, T Maruyama.   

Abstract

The introduction of Freund's complete adjuvant into footpads of mice leads to functional changes of the high endothelial venules (HEV) in the draining lymph nodes. Using an in vitro adhesion assay, increased binding of monocytes and dendritic cells could be seen. These effects are also seen after injection of high doses of INF-gamma. No changes in the expression of vascular addressins, VCAM-1, E selection or ICAM-1 could be observed but the binding of monocytes could be blocked with an antibody against Mac-1. Depletion studies have made it clear that macrophages in the lymph node are not directly involved in the activation of the HEV. The induction of additional adhesion mechanisms on HEV could be an efficient way to recruit inflammatory cells into the lymph node, thereby regulating the local immune response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981147     DOI: 10.1093/intimm/6.8.1195

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  4 in total

1.  CD4+ T cells support cytotoxic T lymphocyte priming by controlling lymph node input.

Authors:  Yosuke Kumamoto; Lisa M Mattei; Stephanie Sellers; Geoffrey W Payne; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

2.  In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue.

Authors:  N Baumgarth; A Kelso
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

3.  The CD4+ T-cell response to protein immunization is independent of accompanying IFN-gamma-producing CD8+ T cells.

Authors:  A G Doyle; L Ramm; A Kelso
Journal:  Immunology       Date:  1998-03       Impact factor: 7.397

4.  Immunotherapy with monoclonal antibodies directed against the immunosuppressive domain of p15E inhibits tumour growth.

Authors:  M S Lang; E Hovenkamp; H F Savelkoul; P Knegt; W Van Ewijk
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.